Frankfurt - Delayed Quote EUR

CONMED Corporation (EC8.F)

66.00 -1.50 (-2.22%)
At close: April 24 at 8:20 AM GMT+2
Loading Chart for EC8.F
DELL
  • Previous Close 67.50
  • Open 66.00
  • Bid 65.00 x 15100
  • Ask 66.00 x 14800
  • Day's Range 66.00 - 66.00
  • 52 Week Range 66.00 - 125.00
  • Volume 12
  • Avg. Volume 0
  • Market Cap (intraday) 2.032B
  • Beta (5Y Monthly) 1.34
  • PE Ratio (TTM) 34.38
  • EPS (TTM) 1.92
  • Earnings Date Apr 24, 2024
  • Forward Dividend & Yield 0.74 (1.09%)
  • Ex-Dividend Date Mar 14, 2024
  • 1y Target Est 159.20

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. The company also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name. In addition, it offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories. Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.

www.conmed.com

4,000

Full Time Employees

December 31

Fiscal Year Ends

Recent News: EC8.F

Performance Overview: EC8.F

Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

EC8.F
34.48%
S&P 500
6.33%

1-Year Return

EC8.F
36.01%
S&P 500
22.70%

3-Year Return

EC8.F
38.54%
S&P 500
21.33%

5-Year Return

EC8.F
1.06%
S&P 500
72.88%

Compare To: EC8.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: EC8.F

Valuation Measures

Annual
As of 4/23/2024
  • Market Cap

    2.06B

  • Enterprise Value

    2.95B

  • Trailing P/E

    35.25

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.82

  • Price/Book (mrq)

    2.65

  • Enterprise Value/Revenue

    2.37

  • Enterprise Value/EBITDA

    15.34

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    5.18%

  • Return on Assets (ttm)

    3.47%

  • Return on Equity (ttm)

    8.16%

  • Revenue (ttm)

    1.24B

  • Net Income Avi to Common (ttm)

    64.46M

  • Diluted EPS (ttm)

    1.92

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    24.3M

  • Total Debt/Equity (mrq)

    118.82%

  • Levered Free Cash Flow (ttm)

    181.56M

Research Analysis: EC8.F

Analyst Price Targets

141.00
159.20 Average
66.00 Current
175.00 High
 

Earnings

Consensus EPS
 

Company Insights: EC8.F

People Also Watch